Founding
members
Expert founding members and complementary
MIB relies on a powerful multidisciplinary network of public, economic, private and academic partners.
This network, which is MIB’s real strength, enables us to benefit from a multitude of skills, resources and expertise.
Thanks to the diversity and complementarity of its founders, MIB is positioned as a scientific and economic center of excellence on an international scale.
Muriel
Altabef
Research Director
at CNRS
Laurent
Baly
President of SATT Sud-Est
Denis
Bertin
Delegate vice-president A*Midex
Coordinator France 2030
Hervé
Brailly
Chairman of the Management Board
Executive Vice President
Jean-Luc Chauvin
Chairman of the CCI
Dr. Divi
Cornec
Director of Inserm Research at Brest University Hospital
François
Crémieux
General Manager, APHM
Nathalie
De Preville
Director of Partnerships
Laboratoires Servier
Pierre
d’Epenoux
CEO
ImCheck Therapeutics
Emilie Garrido-Pradalie
Director of Health Research and Rare Diseases at AP-HM
Arnaud
Mercier
Representative of Métropole
Aix-Marseille
Dr. Daniel
Olive
MIB Project Scientific and Technical Manager
Aurélie
Philippe
Local CNRS
Jean-Philippe
Potier
Pr. Bruno
Quesnel
Directeur Recherche et innovation de l’Institut National du Cancer
Marie
Roumieux
Scientific Operations Manager
Emilie
Royer
Directrice Générale d’Eurobiomed
Chloé
Simon
Co-Director of the Amidex
Foundation
France 2030 Coordinator
Françoise
Simon-Plas
Local Inserm
Jean-Philippe
Tissier Seta
OFU General Manager
Pr. Norbert
Vey
General Manager, Institut Paoli-Calmettes
Muriel
Altabef
Research Director, CNRS
Laurent
Baly
President of SATT
Sud-Est
Denis
Bertin
Delegate Vice-President A*Midex France 2030 Coordinator
Hervé
Brailly
Chairman of the Executive Board
Chief Operating Officer by intermediary
Jean-luc
Chauvin
Chairman of the CCI
Dr. Divi
Cornec
Inserm Research Director at Brest University Hospital
François
Crémieux
General Manager of APHM
Nathalie
De Preville
Director of Partnerships, Laboratoires Servier
Pierre
d’Epenoux
CEO ImCheck Therapeutics
Emilie Garrido-Pradalie
Director of Health Research and Rare Diseases at AP-HM
Arnaud
Mercier
Representative of Métropole Aix-Marseille
Dr. Daniel
Olive
MIB Project Scientific and Technical Manager
Aurélie
Philippe
Local CNRS
Jean-Philippe
Potier
Pr. Bruno
Quesnel
Director of Research and Innovation, French National Cancer Institute
Marie
Roumieux
Scientific Operations Manager
Emilie
Royer
Managing Director, Eurobiomed
Chloé
Simon
Co-Director of the Amidex Foundation
France 2030 Coordinator
Françoise
Simon-Plas
Local Inserm
Jean-Philippe
Tissier Seta
OFU General Manager
Pr. Norbert
Vey
Managing Director, Institut Paoli-Calmettes
Our
partners
